In silico trials of combination immuno-radiation for unresectable hepatocellular carcinoma

Transl Cancer Res. 2023 Apr 28;12(4):709-712. doi: 10.21037/tcr-22-2906. Epub 2023 Mar 31.

Authors

Mishal Mendiratta-Lala¹, Issam El Naqa², Dawn Owen³

Affiliations

¹ Department of Radiology, University of Michigan, Ann Arbor, Michigan, USA.
² Machine Learning Department, Moffitt Cancer Center, Tampa, Florida, USA.
³ Mayo Clinic Rochester, Rochester, Minnesota, USA.

No abstract available

Keywords: Hepatocellular carcinoma (HCC); durvalumab; external beam radiotherapy (EBRT); mathematical modeling.

Publication types

Editorial
Comment